FACULTY
Smoking Cessation: The Importance of Pharmacist Interventions to Successful Outcomes
Activity Date: August 2007
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Glen E. Farr, PharmD
Professor of Clinical Pharmacy
Associate Dean for Continuing Education
University of Tennessee College of Pharmacy
Knoxville, Tennessee
Dr Farr reports receiving honoraria from Abbott Laboratories, Pfizer, Inc, and Sanofi-Aventis.

PARTICIPATING FACULTY

Melody Ryan, PharmD, MPH
Associate Professor
Department of Pharmacy Practice and  Science
University of Kentucky College of Pharmacy
Lexington, Kentucky
Dr Ryan reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Charles Vega, MD
Associate Clinical Professor
Residency Program Director
University of California Irvine Department of Family Medicine
Clinical Co-Director
UCI Program in Medical Education for the Latino Community
University of California Irvine
Orange, California
Dr Vega reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Jill M. Williams, MD
Associate Professor of Psychiatry
Robert Wood Johnson Medical School
Division of Addiction Psychiatry
New Brunswick, New Jersey
Dr Williams reports receiving grants/research support from and serving as a consultant for Pfizer, Inc.

Notice: The following faculty member has disclosed that the article will reference unlabeled/unapproved drugs or products:

Dr Ryan—clonidine and nortriptyline for smoking cessation, combination of nicotine patch with nicotine gum or nasal spray, and combination of bupropion or nortriptyline with nicotine replacement therapy.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?